Back to Archived Journals » Comparative Effectiveness Research » Volume 7

Cost-effectiveness of sunitinib as second-line treatment for gastrointestinal stromal tumor in the People’s Republic of China

Total article views   Abstract views HTML views PDF downloads Totals
5,624 Dovepress* 4,312 1,312+ 413 5,624
Totals 4,312 1,312 413 5,624
*Since 23 January 2017
+Since July 2016

View citations on Google Scholar